Buying led the Tokyo market at the open, with the Nikkei Average slightly higher than the previous day. Advantest hit another record high for the second consecutive day, while Nvidia's record high supported the market. Nissan Motor rebounded for the first time in four sessions, and SanBio administered its cell therapy drug for the first time since its launch.
Buying led the Tokyo stock market on the 6th. The Nikkei Average stood at 70,145.21, up 0.28% from the previous day, while TOPIX was up 0.49%. After the open, the Nikkei Average rose to 70,355.93 and remained above the ¥70,000 level. The broader market was supported by a wide range of stocks, including domestic-demand and financial names.
Top news included Advantest hitting another record high for the second consecutive day, drawing attention to the performance of major semiconductor-related stocks. Nvidia's new record high was also reported to have bolstered investors' appetite for stocks.
Among individual stocks, Nissan Motor rebounded for the first time in four sessions, while SanBio was reported to have administered its cell therapy drug, Akugo intracerebral implantation injection, for the first time since its launch. These developments are believed to have affected market sentiment.